British Equine Veterinary Association (BEVA) and British Equestrian (BEF) working group, the United Kingdom and European equine and equestrian industry has recently faced the challenge of a significant shortage of equine influenza (EI) vaccine. 1 As vaccine supply returns to normal, the pre-existing enhanced EI vaccination schedules introduced in several countries after the 2019 EI epidemic need to be promptly reimplemented to restore and then maintain optimal protective immunity within the horse population. After all, the equine industry must surely remain resolute and guided by scientific principles, as, in the words of the father of modern science, Galileo himself, 'by denying scientific principles one may maintain any paradox'. In this article, the science behind the enhanced EI vaccination schedules, in particular the replacement of annual boosters with a mandatory bi-annual vaccination programme, is reviewed. The clear evidence from experimental, epidemiological and mathematical modelling studies indicates the benefit of bi-annual boosters, and in this editorial, we explore and explain this evidence.
| REMEMBERING THE MATTER OF CONCERNEquine influenza is a highly contagious respiratory disease which remains endemic in horse populations across numerous countries and is characterised by rapid spread and significant morbidity in the immunologically naive. With the introduction of mandatory EI vaccination by most competitive equestrian disciplines after the early 1980s, the scale and number of outbreaks, and corresponding economic losses, have in most years been relatively small. However, disease events such as those experienced in the United Kingdom in 1989, 2 2003 3,4 (Figure 1), and most recently in 2019 5 are portents of EI's epidemic potential, even in vaccinated horse populations.Across Europe during early 2019, an EI epidemic started to emerge with sufficient speed, magnitude and apparent potential for disruption that UK racing was pre-emptively cancelled for 6 days in February, to allow the industry to take stock but thereby incurring significant costs on itself. 1,[5][6][7] Even before racing's shutdown, the British Horseracing Authority (BHA) had already in 2019 recommended booster vaccination of any racehorses that had not been administered EI vaccine in the preceding 6 months. The BHA subsequently increased the frequency of EI booster